MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Expiratory strength in Parkinson’s disease patients? Does time matter?

    R. Guimaraes, F. Cendes, L. Paiva, MF. Satollo, M. Diogo, L. Durans (Campinas, Brazil)

    Objective: To assess the effectiveness of cough in Parkinson’s Disease (PD) patients in mild, moderate and severe disease stages. Background: Parkinson's Disease is the second…
  • 2023 International Congress

    Clinico-genetic analysis of patients with Parkinson’s disease and GBA mutations from a tertiary care teaching centre in India

    S. Kamath, V. Holla, P. Phulpagar, N. Kamble, R. Yadav, B. Muthusamy, PK. Pal (Bangalore, India)

    Objective: To describe the clinico-genetic association of PD patients with heterozygous GBA mutations (PDwG). Background: Parkinson’s disease (PD) is currently understood to be the outcome…
  • 2023 International Congress

    A Retrospective Review of Amantadine in Progressive Supranuclear Palsy

    N. Mcfarland, R. Farrukh, S. Mahn (Gainesville, USA)

    Objective: To determine the efficacy and tolerability of amantadine in Progressive supranuclear palsy (PSP). Background: PSP is one of the most common atypical parkinsonian disorders,…
  • 2023 International Congress

    Gut dysbiosis in Indian Parkinson’s Disease Patients with Constipation

    S. Pavan, M. Ballal, A. Prabhu, B. Das, A. Mutreja, K. Vasudevan (Manipal, India)

    Objective: To analyse the gut microbiome and explore dysbiosis in Indian Parkinson’s Disease patients with and without constipation. Background: Global studies have associated gut dysbiosis…
  • 2023 International Congress

    Potential role of Alpha-synuclein levels in Platelets in GBA-related PD

    G. Uras, S. Lucas, A. Schapira (London, United Kingdom)

    Objective: Identification of a blood biomarker to predict PD diagnosis or to monitor the disease progression. Background: Previous evidence suggests differences in systemic alpha-synuclein levels…
  • 2023 International Congress

    The neuroprotective miRNA family hsa-miR-451 has a distinctive pattern of downregulation in neurodegenerative diseases.

    R. Singh, V. Swarup, I. Ahmad, V. Anand, I. Singh, M. Faruq, A. Srivastava (New Delhi, India)

    Objective: 1.Identification of microRNAs from whole blood PBMCs of SCA2 patients by using NGS.    2.To check the exclusivity of miRNAs in SCA2, SCA1,SCA3,SCA12,HD,ALS,PD and MSA-C…
  • 2023 International Congress

    Characterization of haemodynamic activity in resting-state networks associated with cognitive decline in PD: a fractal analysis approach

    E. Fiorenzato, A. Antonini, L. Weis, R. Biundo, V. D’Onofrio, F. Ferreri, S. Moaveninejad, C. Porcaro (Padova, Italy)

    Objective: To characterize the frequency dependence and the complexity changes of functional connectivity associated with PD cognitive decline. Background: Changes in spontaneous neural activity have…
  • 2023 International Congress

    Uncovering the mechanisms of genotype by environment interaction in an idiopathic Parkinson’s disease model in Drosophila

    P. Olguin, G. Olivares, N. Candia, F. Núñez-Villegas, A. Klein (Santiago, Chile)

    Objective: To identify the genetic basis and the molecular mechanisms that underlie the susceptibility of developing motor defects in response to exposure to pesticides in…
  • 2023 International Congress

    APOE-ɛ4 status and cognitive decline after subthalamic nucleus-deep brain stimulation in Parkinson’s disease: preliminary results of the GENEPARK-DBS study

    A. Sánchez-Soblechero, G. Lafuente, S. Pérez, G. Velilla, M. González-Sánchez, E. González-Turiño, J. Suárez, F. Grandas, V. álvarez, B. Dela Casa (Madrid, Spain)

    Objective: The aim of this study was to evaluate wheter the presence of APOE-ε4 in a cohort of Parkinson’s disease (PD) patients treated with subthalamic…
  • 2023 International Congress

    Novel RAB39B stop mutation in patient with typical Early-Onset Parkinson’s disease

    J. Jacobson, C. Piat, O. Ross, R. Savica (Rochester, USA)

    Objective: N/A Background: RAB proteins are small guanosine triphosphatases (GTPases) that are ubiquitous and expressed in all cell types regulating vesicular transport and intracellular membrane…
  • « Previous Page
  • 1
  • …
  • 63
  • 64
  • 65
  • 66
  • 67
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley